DOTTIKON EXCLUSIVE SYNTHESIS AG manufactures exclusive active pharmaceutical ingredients (APIs), high-quality intermediates and performance chemicals for the world's leading chemical and pharmaceutical industry.
The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioned as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons.
DOTTIKON's one-site strategy allows reduced decision and communication pathways, thus ensuring rapid and efficient project development as well as clear and transparent communication with customers.
DOTTIKON EXCLUSIVE SYNTHESIS AG's roots date back to 1913, when the company was founded under the name of Schweizerische Sprengstoff-Fabrik AG (SSF), a specialist in explosives.
From the 1930s to the 1970s, SSF developed processes for nitration, hydrogenation and oxidation, which evolved into the chemical intermediates business and the production based hazardous chemical reactions that the company still excels in today. In 1987, Ems-Chemie Holding AG purchased the company and changed its name to EMS-Dottikon in 1990. Amid a spin-off from Ems-Chemie Holding in 2005, the company received its current name, DOTTIKON EXCLUSIVE SYNTHESIS AG, and the parent company DOTTIKON ES HOLDING AG's shares went public in an IPO in the main segment of the SIX Swiss Exchange on March 31 of the same year. In 2013, the company celebrated its 100-year anniversary.
More than Half of Net Sales with APIs
22.08.–23.08.2017 Outsourced Pharma San Diego
San Diego, CA, USA
Hyatt Regency La Jolla, Booth no 61
Long Branch, NJ, USA
Ocean Place Resort, Booth no 31
17.10.–18.10.2017 Outsourced Pharma San Francisco
Burlingame, CA, USA
Hyatt Regency San Francisco Airport, Booth no 67
24.10.–26.10.2017 CPhI Worldwide 2017
Messe Frankfurt, Hall 11.1, Booth no 111D30
DOTTIKON EXCLUSIVE SYNTHESIS AG is an entity of SIX-listed DOTTIKON ES HOLDING AG. The stable senior management and shareholder structure of the DOTTIKON ES Group enables sustainable value growth at the manufacturing site in Dottikon, Switzerland.
Board of Directors
Karin Krause (Head of Human Resources)
DOTTIKON is organized around the main processes business and process development, purchasing, production and quality management.
The production facility is located on approximately 600'000 m² in Dottikon (Switzerland), close to Basel and Zurich. About 100'000 m² of the premises are reserved for development of customer-driven production facilities.
DOTTIKON's headquarters are located in Dottikon, Switzerland.
Dottikon Exclusive Synthesis AG
Representative Office US
Dottikon ES America, Inc.
803 W. Trenton Avenue, Suite 1
Morrisville, PA 19067
|Tel||+1 215 295 2295|
|Fax||+1 215 295 2577|